Therapeutic potential of MET inhibitor combined with immune checkpoint blockade in pancreatic cancer

被引：0
|
作者：
Gao, Mei [1 ]
Lin, Miranda [1 ]
Yang, Yachao [2 ]
Kim, Joseph [1 ]
机构：
[1] Univ Kentucky, Lexington, KY USA
[2] Shandong Weihai Municipal Hosp, Weihai, Peoples R China
来源：
CANCER RESEARCH | 2019年 / 79卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2019-3198
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3198
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Prognostic significance and therapeutic potential of the immune checkpoint VISTA in pancreatic cancer
    Zelin Hou
    Yu Pan
    Qinglin Fei
    Yali Lin
    Yuanyuan Zhou
    Ying Liu
    Hongdan Guan
    Xunbin Yu
    Xianchao Lin
    Fengchun Lu
    Heguang Huang
    [J]. Journal of Cancer Research and Clinical Oncology, 2021, 147 : 517 - 531
  • [2] Prognostic significance and therapeutic potential of the immune checkpoint VISTA in pancreatic cancer
    Hou, Zelin
    Pan, Yu
    Fei, Qinglin
    Lin, Yali
    Zhou, Yuanyuan
    Liu, Ying
    Guan, Hongdan
    Yu, Xunbin
    Lin, Xianchao
    Lu, Fengchun
    Huang, Heguang
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2021, 147 (02) : 517 - 531
  • [3] Emerging Role of Immune Checkpoint Blockade in Pancreatic Cancer
    Macherla, Shravanti
    Laks, Shachar
    Naqash, Abdul Rafeh
    Bulumulle, Anushi
    Zervos, Emmanuel
    Muzaffar, Mahvish
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (11)
  • [4] Combined Immune Checkpoint Blockade
    Drake, Charles G.
    [J]. SEMINARS IN ONCOLOGY, 2015, 42 (04) : 656 - 662
  • [5] Immune checkpoint blockade in pancreatic cancer: Trudging through the immune desert
    Li, Xiaoqi
    Gulati, Mansi
    Larson, Alaina C.
    Solheim, Joyce C.
    Jain, Maneesh
    Kumar, Sushil
    Batra, Surinder K.
    [J]. SEMINARS IN CANCER BIOLOGY, 2022, 86 : 14 - 27
  • [6] Immune checkpoint blockade as a potential therapeutic strategy for undifferentiated malignancies
    Devereaux, Kelly A.
    Charu, Vivek
    Zhao, Shuchun
    Charville, Gregory W.
    Bangs, Charles D.
    van de Rijn, Matt
    Cherry, Athena M.
    Natkunam, Yasodha
    [J]. HUMAN PATHOLOGY, 2018, 82 : 39 - 45
  • [7] Combined immune checkpoint blockade as a therapeutic strategy for BRCA1-mutated breast cancer
    Nolan, Emma
    Savas, Peter
    Policheni, Antonia N.
    Darcy, Phillip K.
    Vaillant, Francois
    Mintoff, Christopher P.
    Dushyanthen, Sathana
    Mansour, Mariam
    Pang, Jia-Min B.
    Fox, Stephen B.
    Perou, Charles M.
    Visvader, Jane E.
    Gray, Daniel H. D.
    Loi, Sherene
    Lindeman, Geoffrey J.
    [J]. SCIENCE TRANSLATIONAL MEDICINE, 2017, 9 (393)
  • [8] Combination therapy with immune checkpoint inhibitor and CCK-receptor blockade increases survival of pancreatic cancer
    Smith, Jill P.
    Wang, Shangzi
    Reham, Ajina
    Jablonski, Sandra A.
    Weiner, Louis M.
    [J]. CANCER RESEARCH, 2016, 76
  • [9] Antiangiogenic therapy combined with immune checkpoint blockade in renal cancer
    Teele Kuusk
    Laurence Albiges
    Bernard Escudier
    Nikolaos Grivas
    John Haanen
    Thomas Powles
    Axel Bex
    [J]. Angiogenesis, 2017, 20 : 205 - 215
  • [10] Immune checkpoint blockade as a potential therapeutic target in non-small cell lung cancer
    Yang, Jiali
    Chen, Juan
    Wei, Jun
    Liu, Xiaoming
    Cho, William C.
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2016, 16 (10) : 1209 - 1223
12345